16 February 2023

Diabetes Endocrinology longread Obesity Pharmaceuticals Political

Who deserves Ozempic, anyway?

16 February 2023

Diabetes Obesity Pharmaceuticals

Ozempic arrives back in Australia

13 February 2023

Clinical Obesity

Coming up: Metabolic syndrome in children

9 February 2023

Cardio Diabetes Pharmaceuticals Women

SGLT2 inhibitors may help men’s hearts more

9 February 2023

Cancer Diabetes Public Health

Older diabetics face increased cancer risk

2 February 2023

Diabetes Endocrinology Pharmaceuticals

New diabetes drug wins TGA approval

23 January 2023

Clinical Diabetes Hypertension

Coming up: Preventing diabetic retinopathy

9 December 2022

Clinical Diabetes

Low-carbohydrate diets to manage type 2 diabetes

2 December 2022

Diabetes Obesity PBS TGA

TGA threatens heavy fines for promoting semaglutide

3 November 2022

Diabetes Obesity PBS Pharmaceuticals

It’s a bad time to start patients on -glutides

27 October 2022

Cardio Diabetes

Heart risk falls for diabetes patients

19 October 2022

Diabetes PBS TGA

Medicare stoush goes live on stage

29 September 2022

Cardiology Diabetes Diet Exercise Neurology

Gestational diabetes ups risk of heart and brain disease

8 September 2022

Diabetes Obesity TGA

Semaglutide approved for weight loss, but no supply

28 July 2022

Diabetes Rheumatology

Metformin hope for knee OA

28 July 2022

Diabetes Pharmaceuticals

DPP-4 inhibitors up gallbladder disease risk